π•Œπ•‚ 𝕑𝕣𝕖𝕑𝕒𝕣𝕖𝕀 π•—π•šπ•§π•– π•žπ•šπ•π•π•šπ• π•Ÿ π•§π•’π•”π•”π•šπ•Ÿπ•– 𝕕𝕠𝕀𝕖𝕀 π•šπ•Ÿ 𝕔𝕒𝕀𝕖 𝕠𝕗 π•“π•šπ•£π•• 𝕗𝕝𝕦 π•‘π•’π•Ÿπ••π•–π•žπ•šπ•”

The UK has secured a contract for more than five million doses of a bird flu vaccine, to be used if the H5N1 strain spreads among humans, as part of preparations for any possible influenza pandemic. The UKHSA says at this stage there is no evidence of human-to-human transmission.

There is no evidence at this stage of human-to-human transmission, according to the UK Health Security Agency (UKHSA), which has secured a contract for the doses.

The agency said the purchase is part of “long-established plans” to boost the UK’s access to vaccines “for a wider range of pathogens of pandemic potential”.

Dr Meera Chand, emerging infection lead at the agency, said “early access to vaccines saves lives”.

π”Ήπ•£π•–π•’π•œπ•šπ•Ÿπ•˜ ℕ𝕖𝕨𝕀

Source